Multikinase inhibitors

XL 40 Pill - yellow three-sided, 8mm

Generic Name: cabozantinib

Pill with imprint XL 40 is Yellow, Three-sided and has been identified as Cabometyx 40 mg. It is supplied by Exelixis, Inc.

Cabometyx is used in the treatment of Renal Cell Carcinoma; Hepatocellular Carcinoma; Thyroid Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Cabometyx 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Cabometyx (Cabozantinib [ ka-boe-zan-ti-nib ])-XL 40-40 mg-Yellow-Three-sided
Cabometyx (Cabozantinib [ ka-boe-zan-ti-nib ])-XL 40-40 mg-Yellow-Three-sided

Cabometyx
Generic Name: cabozantinib [ ka-boe-zan-ti-nib ]
Imprint: XL 40
Strength: 40 mg
Color: Yellow
Size: 8.00 mm
Shape: Three-sided
Availability: Prescription only
Drug Class: Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 42388-0025
Inactive Ingredients: Microcrystalline cellulose, Lactose anhydrous, Hydroxypropyl cellulose, Croscarmellose sodium, Silicon dioxide, Magnesium stearate, Hypromelloses, Titanium dioxide, Triacetin, Ferric oxide yellow,
Latest News
Related Drugs